Editorial

A Podcast from Transgene: NGS-Based Biosafety Strategy for Breakthrough Virus-Based Immunotherapies

Transgene is a French biotech developing virus-based immunotherapies. There manufacturing processes deal with breakthrough therapeutic vaccines highly awaited by patients.

It is critical to ensure compliance in a fast and safe way, they chose PathoQuest because NGS is the most suitable and rapid approach to assess the raw materials and biological products for viral contaminants.

EnglishFrenchGermanSpanish